(WASHINGTON) -- The U.S. Department of Justice has charged a former vice president and lawyer at GlaxoSmithKline with trying to cover up evidence that the company was illegally marketing the depression drug Wellbutrin as a weight-loss aid, reports MedPage Today.
Lauren Stevens of Durham, N.C. was charged with one count of obstructing an official proceeding, one count of concealing and falsifying documents to influence a federal agency, and four counts of making false statements to the FDA, according to the FDA.
The indictment doesn't name the company or the drug, but a lawyer for Stevens confirmed to The Wall Street Journal that Stevens was a vice president at GlaxoSmithKline and that the indictment relates to Wellbutrin and an ongoing investigation into the company marketing the depression drug to treat weight loss -- a health issue for which it is not approved.
A spokeswoman for GlaxoSmithKline confirmed that Stevens was employed in the company's legal department and that she is now retired.
Copyright 2010 ABC News Radio